Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank67
3Y CAGR+33.5%
5Y CAGR-11.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+33.5%/yr
vs -25.6%/yr prior
5Y CAGR
-11.7%/yr
Recent acceleration
Acceleration
+59.2pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $18.56M | +5.4% |
| 2024 | $17.62M | +36.6% |
| 2023 | $12.89M | +65.4% |
| 2022 | $7.80M | -91.2% |
| 2021 | $88.76M | +156.5% |
| 2020 | $34.61M | +521.2% |
| 2019 | $5.57M | -78.2% |
| 2018 | $25.51M | +1140.1% |
| 2013 | $2.06M | +46.5% |
| 2012 | $1.40M | - |